SchneiderJ., BitterlichN., VelcovskyH-G, MorrH., KatzN., EigenbrodtE.Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancer. Int J Clin Oncol2002; 7: 145–51.
2.
SchneiderJ., PeltriG., BitterlichN.. Fuzzy logic-based tumor marker profiles including a new marker Tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Anticancer Res2003; 23: 899–906.
3.
SchneiderJ., PhilippM., VelcovskyH-G, MorrH., KatzN.Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19 fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. Anticancer Res2003; 23: 885–94.
4.
LamyP.J., GrenierJ., KramarA., PujolJ.L.Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer. Lung Cancer2000; 29: 197–203.
5.
SiegelS., CastellanN.J.Jr.. Nonparametric statistics for the behavioral sciences (2nd edition). New York: McGraw-Hill, 1988.